Skip to search formSkip to main contentSkip to account menu

pridopidine

Known as: 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidine, huntexil, 4-(3-methanesulfonylphenyl)-1-propylpiperidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
La presente invention concerne le L-tartrate de pridopidine, des compositions et un procede de preparation associes. L'invention… 
2015
2015
This invention provides an isolated compound having the structure as described in the description. The invention also provides… 
2015
2015
The present invention is therapeutically effective as a free flight Dean or a pharmaceutically acceptable thereof… 
2013
2013
The invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntington's disease (HD… 
Review
2013
Review
2013
The available treatment options for Huntington’s disease (HD) are only symptomatic, partly with a limited symptom control and… 
2012
2012
Background Huntington's disease (HD) is a neurodegenerative disorder characterised by hyperkinetic movements (chorea), cognitive… 
2011
2011
The present invention provides Pridopidine (Pridopidine), i.e., 4- (3-methanesulfonyl-yl - phenyl) -L-propyl - piperidine novel… 
2010
2010
O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC…